Other
partners*

Hind Medyouf

Preclinical models, metastasis, single cell approaches.

Affiliation: Georg Speyer Haus and Frankfurt Cancer Institute, Frankfurt am Main, Germany

Main scientific/ clinical interest: Characterisation of disease specific tumor microenvironments. Functional evaluation of tumor-niche dependencies in metastasis and hematological malignancies.  

Techniques/ approaches you will contribute to RISEbrain:  preclinical models, pre-clinical drug testing, RNA sequencing (bulk and single cell), multispectral flow cytometry

Most relevant awards & honors: EMBO YIP; ERC starting grant; José Carreras Career Award

Meet Hind Medyouf

News & Outreach*

10/2013

Invited Speaker

European Macrophage and Dendritic cell society (EMDS) meeting

VIB Ghent, Belgium

06/2023

Invited speaker

European Hematology Association Annual meeting

Frankfurt, Germany

02/2023

Delegation member

EMBO India Research Partnership Tour

India

Achievements*

Mutational hierarchies in myelodysplastic syndromes dynamically adapt and evolve upon therapy response and failure. 

Blood

CRISPR/Cas9-edited NSG mice as PDX models of human leukemia to address the role of niche-derived SPARC

Leukemia

AXL inhibition in macrophages stimulates host-versus-leukemia immunity and eradicates naive and treatment resistant leukemia.

Cancer Discovery

Positions available*

Currently, we are not offering any job positions.